1. 1) Kiasat N, Rezaei-Matehkolaei A, Zarei Mahmoudabadi A, Hamidavi Mohamadpour K, Molavi S, Khoshayand N. Prevalence of vulvovaginal candidiasis in Ahvaz, Southwest Iran: a semi-large scale study. Jundishapur J Microbiol., 12, e89815 (2019).
2. 2) Esteban Barahona-Correa J, Gabriela Calvo-Valderrama M, Marcela Romero-Alvernia D, Angulo-Mora J, Fernanda Alarcon-Figueroa L, Nelcy Rodriguez-Malagon M, Ricardo Garzon-Herazo J. Epidemiology of Candidemia at a University Hospital in Colombia, 2008–2014. Universitas Medica, 60, 3–11 (2019).
3. 3) Xiao M, Sun Z-Y, Kang M, Guo D-W, Liao K, Chen SCA, Kong F, Fan X, Cheng J-W, Hou X, Zhou M-L, Li Y, Yu S-Y, Huang J-J, Wang H, Xu Y-C, China Hosp Invasive Fungal S. Five-year national surveillance of invasive candidiasis: species distribution and azole susceptibility from the China hospital invasive fungal surveillance net (CHIF-NET) study. J. Clin. Microbiol., 56, e00577-18 (2018).
4. 4) Kawabe A, Muraki Y, Inose R, Kusama Y, Goto R, Ebisui A, Ishii S, Ishikane M, Ohge H, Ohmagari N. Trends of antifungal use based on sales data in Japan from 2006 to 2015. Biol. Pharm. Bull., 43, 1248–1252 (2020).
5. 5) Prasad R, Nair R, Banerjee A. Emerging mechanisms of drug resistance in Candida albicans. Prog. Mol. Subcell. Biol., 58, 135–153 (2019).